Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

French drama over sovereign paracetamol is really about a deeper ailment: underinvestment.

The CDC investigates potential bird flu infections in Washington farm workers. Baxter seeks to restore dialysis patient ...

The French drugmaker on Monday announced progress on a deal to sell 50% of its over-the-counter division to Clayton Dubilier ...

By deploying relatable imagery of princesses pooping, Dulcolax has set out to challenge societal norms that teach girls to be ashamed of bodily functions.

The organisation sought the help of the home affairs adviser and law enforcement agencies in the ongoing struggle ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Global investment firm CD&R announced an open offer to buy a 26% stake in Sanofi Consumer Healthcare India for Rs 2,983 crore ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF – Research Report) and ...